{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-087219","form_type":"8-K","ticker":"ZBH","cik":"0001136869","company_name":"ZIMMER BIOMET HOLDINGS, INC.","filed_at":"2025-04-21T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.623644+00:00","generated_at":"2026-05-23T10:00:36.722827+00:00","sec_items":["8.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Zimmer Biomet completes acquisition of Paragon 28 for $13.00/share plus CVR","bullets":["Closing on April 21, 2025; each Paragon 28 share converted to $13.00 cash plus up to $1.00 CVR tied to revenue milestones.","Paragon 28 becomes wholly-owned subsidiary; delisted from NYSE effective April 21, 2025.","Deal strengthens Zimmer Biomet's foot and ankle segment, a ~$5B market growing high-single digits.","Leverages Paragon 28's dedicated sales channel to accelerate ASC penetration and global growth.","Transaction expected to accelerate Zimmer Biomet's weighted-average market growth rate (WAMGR)."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-087219","json":"https://secwatch.observer/filing/0001193125-25-087219.json","markdown":"https://secwatch.observer/filing/0001193125-25-087219.md","text":"https://secwatch.observer/filing/0001193125-25-087219.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1136869/000119312525087219/0001193125-25-087219-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1136869/000119312525087219/d947892d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T10:00:36.722827+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}